Clinical relevance of screening checklists for detecting cancer predisposition syndromes in Asian childhood tumours

• Main Authors: Chan, Sock Hoai, Chew, Winston, Nur Diana Binte Ishak, Lim, Weng Khong, Li, Shao-Tzu, Tan, Sheng Hui, Teo, Jing Xian, Shaw, Tarryn, Chang, Kenneth, Chen, Yong, Iyer, Prasad, Tan, Enrica Ee Kar, Seng, Michaela Su-Fern, Chan, Mei Yoke, Tan, Ah Moy, Low, Sharon Yin Yee, Soh, Shui Yen, Loh, Amos Hong Pheng, Ngeow, Joanne
• Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
• Format: Article
• Language: English
• Published: 2020
• Subjects: Science::Medicine; Cancer Genetics; Paediatric Cancer
• Online Access: https://hdl.handle.net/10356/136846
• Institution: Nanyang Technological University

Assessment of cancer predisposition syndromes (CPS) in childhood tumours is challenging to paediatric oncologists due to inconsistent recognizable clinical phenotypes and family histories, especially in cohorts with unknown prevalence of germline mutations. Screening checklists were developed to facilitate CPS detection in paediatric patients; however, their clinical value have yet been validated. Our study aims to assess the utility of clinical screening checklists validated by genetic sequencing in an Asian cohort of childhood tumours. We evaluated 102 patients under age 18 years recruited over a period of 31 months. Patient records were reviewed against two published checklists and germline mutations in 100 cancer-associated genes were profiled through a combination of whole-exome sequencing and multiplex ligation-dependent probe amplification on blood-derived genomic DNA. Pathogenic germline mutations were identified in ten (10%) patients across six known cancer predisposition genes: TP53, DICER1, NF1, FH, SDHD and VHL. Fifty-four (53%) patients screened positive on both checklists, including all ten pathogenic germline carriers. TP53 was most frequently mutated, affecting five children with adrenocortical carcinoma, sarcomas and diffuse astrocytoma. Disparity in prevalence of germline mutations across tumour types suggested variable genetic susceptibility and implied potential contribution of novel susceptibility genes. Only five (50%) children with pathogenic germline mutations had a family history of cancer. We conclude that CPS screening checklists are adequately sensitive to detect at-risk children and are relevant for clinical application. In addition, our study showed that 10% of Asian paediatric solid tumours have a heritable component, consistent with other populations.